Home > Insider Trading > Filing (0001209191-18-032314)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1073409	Burkhard Blank	420 Saw Mill River Road Ardsley NY 10502	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-18	25,000	$16.50	58,150	No	4	M	Direct
Common Stock	Disposition	2018-05-18	25,000	$23.66	33,150	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2018-05-18	25,000	$0.00	25,000	$16.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000		2027-05-01	No	4	M	Direct

Footnotes

Exercise and sales pursuant to a 10b5-1 plan.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $23.45 to $24.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The shares subject to this option vest over two years from the May 1, 2017 grant date, with the first 25% having vested at the end of six months after the grant date and the remaining 75% vesting in equal quarterly installments over the remainder of such two year period.